Ophthalmology Doctors in Toms River, NJ Accepting Medicare

26 Ophthalmology doctors found. Showing 21 - 26

Jonathan Michael Gloth, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 780 Rt 37 West, Suite 200, Toms River, NJ 08755 Phone: 732-797-1855    Fax: 732-797-1856

Dr. Shravan Savant, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 530 Lakehurst Rd, Toms River, NJ 08755 Phone: 732-797-3883    Fax: 732-797-3866

Dr. Kenneth Joel Davis, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 865 Ocean View Dr, Toms River, NJ 08753 Phone: 732-929-0577

Christine Talamini, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 601 Route 37 W, Toms River, NJ 08755 Phone: 732-244-4400

Dr. Laurel A Feiner, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 40 Bey Lea Rd, #b103, Toms River, NJ 08753 Phone: 732-349-1012    Fax: 732-349-1082

Dr. Vipul K Lakhani, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 413 Lakehurst Rd Bldg 1, Toms River, NJ 08755 Phone: 732-244-4322    Fax: 732-244-4320

News Archive

Oxytocin hormone inhibits fear center in brain, shows study

Frightening experiences do not quickly fade from memory. A team of researchers under the guidance of the University of Bonn Hospital has now been able to demonstrate in a study that the bonding hormone oxytocin inhibits the fear center in the brain and allows fear stimuli to subside more easily.

Karolinska Institute researchers discover novel cancer drug target

Vivolux AB, a drug discovery company specialized in cancer treatment, announced today that data that forms the basis for one of the company's promising projects has been published in the journal Nature Medicine. Researchers at the Karolinska Institute have discovered a novel cancer drug target.

Commonwealth Fund grant to support BIDMC's work on OurNotes

Beth Israel Deaconess Medical Center has received a $450,000 grant from The Commonwealth Fund to develop OurNotes, an initiative to promote active patient engagement in health and illness that invites patients to contribute to their own electronic medical records.

Bristol-Myers Squibb first quarter net sales increase 5% to $3.3 billion

Bristol-Myers Squibb Company today announced first quarter results that included strong sales and earnings growth, and several key R&D milestones—most notably U.S. regulatory approval for YERVOY. The company also confirmed guidance for the year.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)